T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells

被引:50
作者
Rubina K. [1 ]
Kalinina N. [1 ]
Potekhina A.V. [1 ]
Efimenko A. [1 ]
Semina E. [1 ]
Poliakov A. [3 ]
Wilkinson D.G. [3 ]
Parfyonova Y. [2 ]
Tkachuk V. [1 ]
机构
[1] Department of Biological and Medical Chemistry, Faculty of Fundamental Medicine, Lomonosov Moscow State University, 31-5, Lomonosovsky av.
[2] Angiogenesis Laboratory, Russian Cardiology Research and Production Center, 15A, 3rd Cherepkovskaya str.
[3] Division of Developmental Neurobiology, National Institute for Medical Research, The Ridgeway, Mill Hill
基金
俄罗斯基础研究基金会;
关键词
Angiogenesis; Blood vessels; Cadherin; Endothelial cells; Navigating receptor; Vascular biology;
D O I
10.1007/s10456-007-9072-2
中图分类号
学科分类号
摘要
Our previous studies have revealed the abundant expression of T-cadherin-a glycosylphosphatidylinositol (GPI)-anchored member of cadherin superfamily-in endothelial and mural cells in the heart and vasculature. The upregulation of T-cadherin in vascular proliferative disorders such as atherosclerosis and restenosis suggests the involvement of T-cadherin in vascular growth and remodeling. However, the functional significance of this molecule in the vasculature remains unknown. The effect of T-cadherin on angiogenesis in vivo was evaluated using Matrigel implant model. We demonstrate that T-cadherin overexpression in L929 cells injected in Matrigel inhibits neovascularization of the plug. In vitro T-cadherin inhibits the directional migration of endothelial cells, capillary growth, and tube formation but has no effect on endothelial cell proliferation, adhesion, or apoptosis in vitro. These data suggest that T-cadherin expressed in the stroma could act as a negative guidance cue for the ingrowing blood vessels and thus could have an important potential therapeutic application. © 2007 Springer Science + Business Media B.V.
引用
收藏
页码:183 / 195
页数:12
相关论文
共 52 条
[1]
Cavallaro U., Leibner S., Dejana E., Endothelial cadherins and tumor angiogenesis, Exp Cell Res, 312, pp. 659-667, (2006)
[2]
George S.J., Beeching C.A., Cadherin:catenin complex: A novel regulator of vascular smooth muscle cells behaviour, Atherosclerosis, 188, pp. 1-11, (2006)
[3]
Gumbiner B.M., Regulation of cadherin-mediated adhesion in morphogenesis, Nature Rev Mol Cell Biol, 6, pp. 622-634, (2005)
[4]
Perez-Moreno M., Jamora C., Fuchs E., Sticky business: Orchestrating cellular signals at adherens junctions, Cell, 112, pp. 535-548, (2003)
[5]
Rubina K.A., Kalinina N.I., Bochkov V.N., Parfyonova Ye.V., Tkachuk V.A., T-cadherin as an antiadhesive and guidance molecule interacting with low density lipoproteins, Annals EAS, pp. 1-14, (2005)
[6]
Ranscht B., Dours-Zimmermann M.T., T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region, Neuron, 7, pp. 391-402, (1991)
[7]
Rubina K.A., Tkachuk V.A., Antiadhesive molecule T-cadherin is an atypical low-density lipoprotein receptor in vascular cells, RJ Physiol, 90, pp. 968-986, (2004)
[8]
Philippova M.P., Bochkov V.N., Stambolsky D.V., Tkachuk V.A., Resink T., T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domain of vascular smooth muscle cells, FEBS Lett, 129, pp. 201-210, (1998)
[9]
Ivanov D., Philippova M., Antropova J., Gubaeva F., Iljinskaya O., Tararak E., Bochkov V., Erne P., Resink T., Tkachuk V., Expression of cell adhesion molecule T-cadherin in the human vasculature, Histochem Cell Biol, 115, pp. 231-242, (2001)
[10]
Kudrjashova E., Bashtrikov P., Bochkov V., Parfyonova Y., Tkachuk V., Antropova J., Iljinskaya O., Tararak E., Erne P., Ivanov D., Philippova M., Resink T.J., Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis, Histochem Cell Biol, 118, pp. 281-290, (2002)